Robert Schoch

3.6k total citations · 1 hit paper
21 papers, 2.3k citations indexed

About

Robert Schoch is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Robert Schoch has authored 21 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 8 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Robert Schoch's work include Chronic Lymphocytic Leukemia Research (7 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Robert Schoch is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Robert Schoch collaborates with scholars based in Germany, Spain and United States. Robert Schoch's co-authors include Carlo Finelli, Valeria Santini, David R. McKenzie, Jay T. Backstrom, Pierre Fenaux, Alan F. List, Aristoteles Giagounidis, Eva Hellström‐Lindberg, Norbert Gattermann and John C. Byrd and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Robert Schoch

21 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

2009 1.8k citations Pierre Fenaux, Ghulam J. Mufti et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Schoch Germany	12	1.7k	972	604	352	282	21	2.3k
P. Wijermans Netherlands	21	1.5k 0.9×	978 1.0×	531 0.9×	304 0.9×	345 1.2×	56	2.1k
Angelo Guerrasio Italy	24	938 0.5×	787 0.8×	547 0.9×	315 0.9×	255 0.9×	105	1.7k
Anna Tamburini Italy	20	1.1k 0.6×	611 0.6×	494 0.8×	415 1.2×	256 0.9×	40	1.7k
Musa Yılmaz United States	25	1.5k 0.9×	689 0.7×	596 1.0×	641 1.8×	553 2.0×	149	2.0k
H. Pralle Germany	21	1.3k 0.7×	275 0.3×	869 1.4×	267 0.8×	284 1.0×	65	1.8k
Hiroto Miwa Japan	22	859 0.5×	693 0.7×	215 0.4×	435 1.2×	266 0.9×	44	1.5k
Joan Besalduch Spain	20	868 0.5×	464 0.5×	327 0.5×	316 0.9×	408 1.4×	44	1.4k
Michal Bar‐Natan United States	15	719 0.4×	524 0.5×	364 0.6×	98 0.3×	312 1.1×	41	1.3k
Fumiharu Yagasaki Japan	20	1.2k 0.7×	526 0.5×	333 0.6×	607 1.7×	217 0.8×	61	1.5k
M Giralt Spain	19	638 0.4×	522 0.5×	604 1.0×	100 0.3×	96 0.3×	50	1.7k

Countries citing papers authored by Robert Schoch

Since Specialization

Citations

This map shows the geographic impact of Robert Schoch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Schoch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Schoch more than expected).

Fields of papers citing papers by Robert Schoch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Schoch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Schoch. The network helps show where Robert Schoch may publish in the future.

Co-authorship network of co-authors of Robert Schoch

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Schoch. A scholar is included among the top collaborators of Robert Schoch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Schoch. Robert Schoch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Fenaux, Pierre, Ghulam J. Mufti, Eva Hellström‐Lindberg, et al.. (2009). Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. The Lancet Oncology. 10(3). 223–232. 1756 indexed citations breakdown →

2.

Calasanz, Marı́a José, Reiner Siebert, Robert Schoch, et al.. (2007). Multicolor interphase cytogenetics for the study of plasma cell dyscrasias. Oncology Reports. 18(5). 1099–106. 4 indexed citations

3.

Fenaux, Pierre, G J Mufti, Valeria Santini, et al.. (2007). Azacitidine (AZA) Treatment Prolongs Overall Survival (OS) in Higher-Risk MDS Patients Compared with Conventional Care Regimens (CCR): Results of the AZA-001 Phase III Study.. Blood. 110(11). 817–817. 74 indexed citations

4.

Hoffmann, Christian, Roland Repp, Robert Schoch, et al.. (2006). Successful autologous stem cell transplantation in a severely immunocompromised patient with relapsed AIDS-related B-cell lymphoma.. PubMed. 11(2). 73–6. 3 indexed citations

5.

Moosig, Frank, Robert Schoch, & Michael Kneba. (2006). Die T-Large Granular Lymphocyte Leukämie (T-LGL-Leukämie) –. Zeitschrift für Rheumatologie. 65(5). 447–451. 1 indexed citations

6.

Humpe, Andreas, Christian Beck, Robert Schoch, Michael Kneba, & Heinz‐August Horst. (2005). Establishment and optimization of a flow cytometric method for evaluation of viability of CD34+ cells after cryopreservation and comparison with trypan blue exclusion staining. Transfusion. 45(7). 1208–1213. 36 indexed citations

7.

Dugas, Martin, D. Messerer, Joerg Hasford, et al.. (2003). German Multicenter Study Group for Adult ALL (GMALL): recruitment in comparison to ALL incidence and its impact on study results. Annals of Hematology. 82(2). 83–87. 9 indexed citations

8.

Kollmannsberger, Christian, Oliver Rick, H. G. Derigs, et al.. (2002). Activity of Oxaliplatin in Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer: A Study of the German Testicular Cancer Study Group. Journal of Clinical Oncology. 20(8). 2031–2037. 83 indexed citations

9.

Harder, Lana, Stefan Gesk, Robert Schoch, et al.. (2001). Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia. Genes Chromosomes and Cancer. 31(1). 10–14. 14 indexed citations

10.

Schoch, Robert, Philippe Schafhausen, Stefan Jenisch, et al.. (2001). Semiquantitative reverse transcription polymerase chain reaction analysis for detection of bcr/abl rearrangement using RNA extracts from bone marrow aspirates compared with glass slide smears after 0, 2 and 4 d of storage. British Journal of Haematology. 115(3). 583–587. 3 indexed citations

11.

Martı́n-Subero, José I., Lana Harder, Stefan Gesk, et al.. (2001). Amplification of ERBB2, RARA, and TOP2A genes in a myelodysplastic syndrome transforming to acute myeloid leukemia. Cancer Genetics and Cytogenetics. 127(2). 174–176. 10 indexed citations

12.

Dreger, Peter, Nils von Neuhoff, R. Kuse, et al.. (1998). Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?. British Journal of Cancer. 77(12). 2291–2297. 43 indexed citations

13.

Haferlach, Torsten, Helmut Löffler, Christina Nickenig, et al.. (1998). Cell lineage specific involvement in acute promyelocytic leukaemia (APL) using a combination of May‐Grünwald‐Giemsa staining and fluorescence in situ hybridization techniques for the detection of the translocation t(15;17)(q22;q12). British Journal of Haematology. 103(1). 93–99. 20 indexed citations

14.

Haferlach, Torsten, Robert Schoch, K Weber-Matthiesen, et al.. (1997). New insights into the biology of Philadelphia‐chromosome‐positive acute lymphoblastic leukaemia using a combination of May‐Grünwald‐Giemsa staining and fluorescence in situ hybridization techniques at the single cell level. British Journal of Haematology. 99(2). 452–459. 15 indexed citations

15.

Haferlach, Torsten, Christina Nickenig, Robert Schoch, et al.. (1997). Which compartments are involved in Philadelphia‐chromosome positive chronic myeloid leukaemia? An answer at the single cell level by combining May‐Grünwald‐Giemsa staining and fluorescence in situ hybridization techniques. British Journal of Haematology. 97(1). 99–106. 41 indexed citations

16.

Suttorp, Meinolf, Matthias Ritgen, Nils von Neuhoff, Robert Schoch, & Norbert Schmitz. (1997). Blood on Filter Paper as a Readily Available Source of bcr-abl Rearranged mRNA. Blood. 90(4). 1713–1715. 4 indexed citations

17.

Suttorp, Meinolf, Matthias Ritgen, Nils von Neuhoff, Robert Schoch, & Norbert Schmitz. (1997). Blood on Filter Paper as a Readily Available Source of bcr-abl Rearranged mRNA. Blood. 90(4). 1713–1715. 3 indexed citations

18.

Schoch, Robert, Stefan Jenisch, Torsten Haferlach, et al.. (1996). Glass slide smears are a suitable source for RT‐PCR‐based analysis of chromosomal aberrations in leukaemias. British Journal of Haematology. 92(1). 140–142. 15 indexed citations

19.

Haferlach, Torsten, H. Löffler, Robert Schoch, et al.. (1996). The abnormal eosinophils are part of the leukemic cell population in acute myelomonocytic leukemia with abnormal eosinophils (AML M4Eo) and carry the pericentric inversion 16: a combination of May-Grunwald- Giemsa staining and fluorescence in situ hybridization. Blood. 87(6). 2459–2463. 49 indexed citations

20.

Schoch, Robert, et al.. (1988). High dosage testosterone propionate induces copulatory behavior in the obese male Zucker rat. Physiology & Behavior. 43(3). 321–324. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact